MAPT and Alzheimer disease: Overexpression of IL-1β in 3xTg AD mice exacerbated tau hyperphosphorylation within one month [41], while blocking IL-1β signaling via IL-1 receptor antagonist (IL-1ra) or anti-IL-1β antibody reversed the cognitive impairment with a diminished tau pathology [83, 84].